Can-Fite BioPharma Ltd. (CANF)

AI Score

Unlock

1.20

-0.03 (-2.44%)

At close: Apr 17, 2025, 3:59 PM

1.20

0.00%

After-hours: Apr 17, 2025, 07:53 PM EDT

Can-Fite BioPharma Cash Flow Statement

Financials in USD. Fiscal year is January - December.

Fiscal Year	Q2 2024	Q1 2024	Q4 2023	Q3 2023	Q2 2023	Q1 2023	Q4 2022	Q3 2022	Q2 2022	Q1 2022	Q4 2021	Q3 2021	Q2 2021	Q1 2021	Q4 2020	Q3 2020	Q2 2020	Q1 2020	Q4 2019	Q3 2019	Q2 2019	Q1 2019	Q4 2018	Q3 2018	Q2 2018	Q1 2018	Q4 2017	Q3 2017	Q2 2017	Q1 2017	Q4 2016	Q3 2016	Q2 2016	Q1 2016
Period Ending	Jun 30, 2024	Mar 31, 2024	Dec 31, 2023	Sep 30, 2023	Jun 30, 2023	Mar 31, 2023	Dec 31, 2022	Sep 30, 2022	Jun 30, 2022	Mar 31, 2022	Dec 31, 2021	Sep 30, 2021	Jun 30, 2021	Mar 31, 2021	Dec 31, 2020	Sep 30, 2020	Jun 30, 2020	Mar 31, 2020	Dec 31, 2019	Sep 30, 2019	Jun 30, 2019	Mar 31, 2019	Dec 31, 2018	Sep 30, 2018	Jun 30, 2018	Mar 31, 2018	Dec 31, 2017	Sep 30, 2017	Jun 30, 2017	Mar 31, 2017	Dec 31, 2016	Sep 30, 2016	Jun 30, 2016	Mar 31, 2016
Net Income	-1.98M	-1.98M	-1.65M	-1.76M	-1.67M	-2.55M	-3.02M	-2.53M	-2.19M	-2.43M	-4.12M	-3.4M	-3.22M	-1.88M	-3.63M	-2.58M	-3.89M	-4.34M	-4.78M	-2.95M	-3.06M	-1.83M	-3.43M	-177K	-1.24M	-1.72M	-2.38M	-541.4K	-2.13M	-1.28M	-3.24M	-2.16M	-1.4M	-1.53M
Depreciation & Amortization	500.00	500.00	n/a	n/a	n/a	n/a	9.24K	n/a	n/a	n/a	7.24K	n/a	n/a	n/a	7.24K	n/a	n/a	n/a	28.34K	n/a	n/a	n/a	340.58	n/a	n/a	n/a	6.34K	n/a	n/a	n/a	4.34K	n/a	n/a	n/a
Stock-Based Compensation	96.5K	96.5K	261K	-95K	95K	n/a	263K	-135K	135K	n/a	466K	-234K	234K	n/a	355K	-99K	99K	n/a	385K	-151K	151K	n/a	535K	-424K	424K	n/a	192K	-94.19K	95K	n/a	309K	-189.12K	135.04K	n/a
Other Working Capital	-322K	-322K	n/a	n/a	n/a	n/a	-574K	n/a	n/a	n/a	279K	n/a	n/a	n/a	-2.45M	n/a	n/a	n/a	242K	n/a	n/a	n/a	728K	n/a	n/a	n/a	1.14M	n/a	n/a	n/a	1.53M	n/a	n/a	n/a
Other Non-Cash Items	185.5K	185.5K	1.39M	1.86M	1.57M	2.55M	2.76M	2.66M	2.06M	2.43M	3.65M	3.63M	2.98M	1.88M	3.28M	2.67M	3.79M	4.34M	4.4M	3.1M	2.91M	1.83M	2.89M	601K	820K	1.72M	2.19M	635.59K	2.03M	1.28M	2.94M	2.35M	1.27M	1.53M
Deferred Income Tax	n/a	n/a	n/a	n/a	n/a	n/a	-8.7M	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	-0.00	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a
Change in Working Capital	-322K	-322K	n/a	n/a	n/a	n/a	158.07K	n/a	n/a	n/a	158.07K	n/a	n/a	n/a	158.07K	n/a	n/a	n/a	-301.26K	n/a	n/a	n/a	-301.26K	n/a	n/a	n/a	-301.26K	n/a	n/a	n/a	-301.26K	n/a	n/a	n/a
Operating Cash Flow	-2.02M	-2.02M	n/a	n/a	95K	n/a	-8.27M	-135K	135K	n/a	-10.47M	n/a	n/a	n/a	-10.47M	n/a	n/a	n/a	-6.77M	n/a	n/a	n/a	-124.78K	n/a	n/a	n/a	-5.52M	n/a	n/a	n/a	-4.9M	n/a	n/a	n/a
Capital Expenditures	-2K	-2K	n/a	n/a	n/a	n/a	-9.04K	n/a	n/a	n/a	-24.04K	n/a	n/a	n/a	-24.04K	n/a	n/a	n/a	4.43K	n/a	n/a	n/a	4.43K	n/a	n/a	n/a	4.43K	n/a	n/a	n/a	4.43K	n/a	n/a	n/a
Cash Acquisitions	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a
Purchase of Investments	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a
Sales Maturities Of Investments	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	-534K	n/a	n/a	n/a	n/a	n/a	n/a	n/a
Other Investing Acitivies	2.25M	2.25M	n/a	n/a	n/a	n/a	-15.42M	n/a	n/a	n/a	-915.08K	n/a	n/a	n/a	-915.08K	n/a	n/a	n/a	-21.12K	n/a	n/a	n/a	-21.12K	n/a	n/a	n/a	-21.12K	n/a	n/a	n/a	-21.12K	n/a	n/a	n/a
Investing Cash Flow	2.25M	2.25M	n/a	n/a	n/a	n/a	-15.42M	n/a	n/a	n/a	-939.12K	n/a	n/a	n/a	-939.12K	n/a	n/a	n/a	-16.69K	n/a	n/a	n/a	-16.69K	n/a	n/a	n/a	-550.69K	n/a	n/a	n/a	-16.69K	n/a	n/a	n/a
Debt Repayment	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a
Common Stock Repurchased	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a
Dividend Paid	n/a	n/a	n/a	n/a	n/a	n/a	-2.59M	n/a	n/a	n/a	-715K	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a
Other Financial Acitivies	n/a	n/a	n/a	n/a	n/a	n/a	23.05M	n/a	n/a	n/a	18.4M	n/a	n/a	n/a	17.68M	n/a	n/a	n/a	-513.48K	n/a	n/a	n/a	-513.48K	n/a	n/a	n/a	-513.48K	n/a	n/a	n/a	-513.48K	n/a	n/a	n/a
Financial Cash Flow	n/a	n/a	n/a	n/a	n/a	n/a	20.46M	n/a	n/a	n/a	17.68M	n/a	n/a	n/a	17.68M	n/a	n/a	n/a	-513.48K	n/a	n/a	n/a	-513.48K	n/a	n/a	n/a	-513.48K	n/a	n/a	n/a	-513.48K	n/a	n/a	n/a
Net Cash Flow	220.5K	220.5K	n/a	-75K	2.19M	-1.71M	-749K	2.02M	135K	n/a	6.15M	n/a	n/a	n/a	6.15M	n/a	n/a	n/a	-7.45M	n/a	n/a	n/a	-804.98K	n/a	n/a	n/a	-6.73M	n/a	n/a	n/a	-5.58M	n/a	n/a	n/a
Free Cash Flow	-2.02M	-2.02M	n/a	n/a	95K	n/a	-8.27M	-135K	135K	n/a	-10.49M	n/a	n/a	n/a	-10.49M	n/a	n/a	n/a	-6.77M	n/a	n/a	n/a	-120.36K	n/a	n/a	n/a	-5.51M	n/a	n/a	n/a	-4.9M	n/a	n/a	n/a